Caner Saygin
- Hematology top 5%
- Acute Myeloid Leukemia Research 9
- Multiple Myeloma Research and Treatments 2
- Oncology top 10%
- Cancer Cells and Metastasis 7
- CAR-T cell therapy research 2
- Cancer Research top 10%
- Cancer Genomics and Diagnostics 3
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research 3
-
- Acute Lymphoblastic Leukemia research 5
-
- Cancer Research and Treatments 2
- Co-authors
- Justin D. LathiaOfer ReizesHetty E. CarrawayRavindra MajetiDaniela MateiAndrew WiechertKirk E. CahillPraveena Thiagarajan
- Cited by
- HematologyOncologyCancer Research
- Partner nations
- United StatesTürkiyeIndia
In The Last Decade
Caner Saygin
24 papers receiving 760 citations
Hit Papers
Peers
Comparison fields: 5 of 68
- Hematology 156
- Oncology 337
- Cancer Research 181
- Genetics 87
- Molecular Biology 426
Countries citing papers authored by Caner Saygin
This map shows the geographic impact of Caner Saygin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caner Saygin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caner Saygin more than expected).
Fields of papers citing papers by Caner Saygin
This network shows the impact of papers produced by Caner Saygin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caner Saygin. The network helps show where Caner Saygin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Caner Saygin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 5 | |
| 5 | 2021 | 9 | |
| 6 | 2021 | 17 | |
| 7 | 2021 | 29 | |
| 8 | 2020 | 32 | |
| 9 | 2019 | 23 | |
| 10 | Targeting Cancer Stemness in the Clinic: From Hype to Hopebreakdown → | 2018 | 367 |
| 11 | 2017 | 16 | |
| 12 | 2017 | 115 | |
| 13 | 2017 | 37 | |
| 14 | 2016 | 9 | |
| 15 | 2016 | 9 | |
| 16 | 2016 | 2 | |
| 17 | 2016 | 1 | |
| 18 | 2016 | 2 | |
| 19 | 2015 | 8 | |
| 20 | 2013 | 8 |
About Caner Saygin
Caner Saygin is a scholar working on Hematology, Genetics and Oncology, having authored 27 papers that have together received 767 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (9 papers), Cancer Cells and Metastasis (7 papers), Acute Lymphoblastic Leukemia research (5 papers), Chronic Lymphocytic Leukemia Research (3 papers), Cancer Genomics and Diagnostics (3 papers), Cancer Research and Treatments (2 papers), CAR-T cell therapy research (2 papers) and Multiple Myeloma Research and Treatments (2 papers). The work is most often cited by research in Hematology (156 citations), Oncology (337 citations) and Cancer Research (181 citations). Caner Saygin has collaborated with scholars based in United States, Türkiye and India. Frequent co-authors include Justin D. Lathia, Ofer Reizes, Hetty E. Carraway, Ravindra Majeti, Daniela Matei, Andrew Wiechert, Kirk E. Cahill, Praveena Thiagarajan, Masahiro Hitomi and Anand Patel. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.